{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,27]],"date-time":"2026-10-27T13:11:07Z","timestamp":1793106667866,"version":"4.5.0"},"reference-count":87,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,2,23]],"date-time":"2026-02-23T00:00:00Z","timestamp":1771804800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100006482","name":"Council on Ocean Affairs Science and Technology, California State University","doi-asserted-by":"publisher","award":["T32 GM139801"],"award-info":[{"award-number":["T32 GM139801"]}],"id":[{"id":"10.13039\/100006482","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100007313","name":"University of Texas MD Anderson Cancer Center","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007313","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000054","name":"National Cancer Institute","doi-asserted-by":"publisher","award":["R01 CA281962"],"award-info":[{"award-number":["R01 CA281962"]}],"id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000054","name":"National Cancer Institute","doi-asserted-by":"publisher","award":["R21 3022991"],"award-info":[{"award-number":["R21 3022991"]}],"id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000054","name":"National Cancer Institute","doi-asserted-by":"publisher","award":["R21 CA28378"],"award-info":[{"award-number":["R21 CA28378"]}],"id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000057","name":"National Institute of General Medical Sciences","doi-asserted-by":"publisher","award":["T32 GM139801"],"award-info":[{"award-number":["T32 GM139801"]}],"id":[{"id":"10.13039\/100000057","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["cell.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Trends in Cancer"],"published-print":{"date-parts":[[2026,6]]},"DOI":"10.1016\/j.trecan.2026.02.006","type":"journal-article","created":{"date-parts":[[2026,4,6]],"date-time":"2026-04-06T03:03:34Z","timestamp":1775444614000},"page":"495-509","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"title":["LGR5: from stem cell marker to therapeutic target"],"prefix":"10.1016","volume":"12","author":[{"given":"Peyton C.","family":"High","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maya G.","family":"Cappellino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tiffani A.","family":"Blackburn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3244-6096","authenticated-orcid":false,"given":"Kendra S.","family":"Carmon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.trecan.2026.02.006_bb0005","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1006\/bbrc.1998.8774","article-title":"Identification and cloning of an orphan G protein-coupled receptor of the glycoprotein hormone receptor subfamily","volume":"247","author":"McDonald","year":"1998","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.trecan.2026.02.006_bb0010","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1006\/bbrc.1998.9882","article-title":"Identification of a novel seven-transmembrane receptor with homology to glycoprotein receptors and its expression in the adult and developing mouse","volume":"254","author":"Hermey","year":"1999","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.trecan.2026.02.006_bb0015","doi-asserted-by":"crossref","first-page":"1830","DOI":"10.1210\/mend.12.12.0211","article-title":"Characterization of two LGR genes homologous to gonadotropin and thyrotropin receptors with extracellular leucine-rich repeats and a G protein-coupled, seven-transmembrane region","volume":"12","author":"Hsu","year":"1998","journal-title":"Mol. Endocrinol."},{"key":"10.1016\/j.trecan.2026.02.006_bb0020","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1053\/j.gastro.2014.05.007","article-title":"Stem cells marked by the R-spondin receptor LGR5","volume":"147","author":"Koo","year":"2014","journal-title":"Gastroenterology"},{"key":"10.1016\/j.trecan.2026.02.006_bb0025","doi-asserted-by":"crossref","first-page":"7145","DOI":"10.1038\/s41467-024-51559-4","article-title":"Lgr5 marks stem\/progenitor cells contributing to epithelial and muscle development in the mouse esophagus","volume":"15","author":"Kostic","year":"2024","journal-title":"Nat. Commun."},{"key":"10.1016\/j.trecan.2026.02.006_bb0030","doi-asserted-by":"crossref","DOI":"10.1016\/j.celrep.2020.108535","article-title":"Lgr5 marks adult progenitor cells contributing to skeletal muscle regeneration and sarcoma formation","volume":"33","author":"Leung","year":"2020","journal-title":"Cell Rep."},{"key":"10.1016\/j.trecan.2026.02.006_bb0035","doi-asserted-by":"crossref","first-page":"10266","DOI":"10.1038\/s41467-025-65140-0","article-title":"Tripotent Lgr5 stem cells in the posterior tongue generate lingual, taste, and salivary gland lineages","volume":"16","author":"Verweij","year":"2025","journal-title":"Nat. Commun."},{"key":"10.1016\/j.trecan.2026.02.006_bb0040","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1038\/s41580-020-0278-0","article-title":"Cell fate specification and differentiation in the adult mammalian intestine","volume":"22","author":"Beumer","year":"2021","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"10.1016\/j.trecan.2026.02.006_bb0045","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1038\/s41392-025-02360-2","article-title":"Cancer stem cells: landscape, challenges and emerging therapeutic innovations","volume":"10","author":"Lee","year":"2025","journal-title":"Signal Transduct. Target. Ther."},{"key":"10.1016\/j.trecan.2026.02.006_bb0050","doi-asserted-by":"crossref","DOI":"10.1016\/j.canlet.2022.215725","article-title":"LGR4 cooperates with PrPc to endow the stemness of colorectal cancer stem cells contributing to tumorigenesis and liver metastasis","volume":"540","author":"Cheng","year":"2022","journal-title":"Cancer Lett."},{"key":"10.1016\/j.trecan.2026.02.006_bb0055","doi-asserted-by":"crossref","first-page":"11452","DOI":"10.1073\/pnas.1106083108","article-title":"R-spondins function as ligands of the orphan receptors LGR4 and LGR5 to regulate Wnt\/\u03b2-catenin signaling","volume":"108","author":"Carmon","year":"2011","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.trecan.2026.02.006_bb0060","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1038\/nature10337","article-title":"Lgr5 homologues associate with Wnt receptors and mediate R-spondin signalling","volume":"476","author":"de Lau","year":"2011","journal-title":"Nature"},{"key":"10.1016\/j.trecan.2026.02.006_bb0065","doi-asserted-by":"crossref","first-page":"1055","DOI":"10.1038\/embor.2011.175","article-title":"LGR4 and LGR5 are R-spondin receptors mediating Wnt\/\u03b2-catenin and Wnt\/PCP signalling","volume":"12","author":"Glinka","year":"2011","journal-title":"EMBO Rep."},{"key":"10.1016\/j.trecan.2026.02.006_bb0070","doi-asserted-by":"crossref","first-page":"1124","DOI":"10.1038\/nm.4409","article-title":"Cancer stem cells revisited","volume":"23","author":"Batlle","year":"2017","journal-title":"Nat. Med."},{"key":"10.1016\/j.trecan.2026.02.006_bb0075","doi-asserted-by":"crossref","first-page":"14989","DOI":"10.1074\/jbc.M117.786798","article-title":"LGR5 receptor promotes cell\u2013cell adhesion in stem cells and colon cancer cells via the IQGAP1\u2013Rac1 pathway","volume":"292","author":"Carmon","year":"2017","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.trecan.2026.02.006_bb0080","doi-asserted-by":"crossref","first-page":"7551","DOI":"10.1128\/MCB.01034-07","article-title":"Wnt\/beta-catenin is essential for intestinal homeostasis and maintenance of intestinal stem cells","volume":"27","author":"Fevr","year":"2007","journal-title":"Mol. Cell. Biol."},{"key":"10.1016\/j.trecan.2026.02.006_bb0085","doi-asserted-by":"crossref","first-page":"1003","DOI":"10.1038\/nature06196","article-title":"Identification of stem cells in small intestine and colon by marker gene Lgr5","volume":"449","author":"Barker","year":"2007","journal-title":"Nature"},{"key":"10.1016\/j.trecan.2026.02.006_bb0090","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1038\/nature07935","article-title":"Single Lgr5 stem cells build crypt-villus structures in vitro without a mesenchymal niche","volume":"459","author":"Sato","year":"2009","journal-title":"Nature"},{"key":"10.1016\/j.trecan.2026.02.006_bb0095","doi-asserted-by":"crossref","first-page":"618","DOI":"10.1038\/nm.2695","article-title":"Functional engraftment of colon epithelium expanded in vitro from a single adult Lgr5+ stem cell","volume":"18","author":"Yui","year":"2012","journal-title":"Nat. Med."},{"key":"10.1016\/j.trecan.2026.02.006_bb0100","doi-asserted-by":"crossref","first-page":"9736","DOI":"10.1128\/MCB.24.22.9736-9743.2004","article-title":"Neonatal lethality of LGR5 null mice is associated with ankyloglossia and gastrointestinal distension","volume":"24","author":"Morita","year":"2004","journal-title":"Mol. Cell. Biol."},{"key":"10.1016\/j.trecan.2026.02.006_bb0105","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1038\/nature10408","article-title":"A reserve stem cell population in small intestine renders Lgr5-positive cells dispensable","volume":"478","author":"Tian","year":"2011","journal-title":"Nature"},{"key":"10.1016\/j.trecan.2026.02.006_bb0110","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1073\/pnas.1118857109","article-title":"The intestinal stem cell markers Bmi1 and Lgr5 identify two functionally distinct populations","volume":"109","author":"Yan","year":"2012","journal-title":"Proc. Natl. Acad. Sci."},{"key":"10.1016\/j.trecan.2026.02.006_bb0115","first-page":"572","article-title":"Targeted activation of ferroptosis in colorectal cancer via LGR4 targeting overcomes acquired drug resistance","volume":"5","author":"Zheng","year":"2024","journal-title":"Nat. Can."},{"key":"10.1016\/j.trecan.2026.02.006_bb0120","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1093\/jb\/mvw077","article-title":"Generation and characterization of monoclonal antibodies against human LGR6","volume":"161","author":"Funahashi","year":"2017","journal-title":"J. Biochem. (Tokyo)"},{"key":"10.1016\/j.trecan.2026.02.006_bb0125","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1016\/j.stem.2019.12.011","article-title":"Ascl2-dependent cell dedifferentiation drives regeneration of ablated intestinal stem cells","volume":"26","author":"Murata","year":"2020","journal-title":"Cell Stem Cell"},{"key":"10.1016\/j.trecan.2026.02.006_bb0130","doi-asserted-by":"crossref","DOI":"10.1016\/j.celrep.2020.108633","article-title":"A constant pool of Lgr5+ intestinal stem cells is required for intestinal homeostasis","volume":"34","author":"Tan","year":"2021","journal-title":"Cell Rep."},{"key":"10.1016\/j.trecan.2026.02.006_bb0135","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1038\/nature15382","article-title":"Yap-dependent reprogramming of Lgr5+ stem cells drives intestinal regeneration and cancer","volume":"526","author":"Gregorieff","year":"2015","journal-title":"Nature"},{"key":"10.1016\/j.trecan.2026.02.006_bb0140","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/j.stem.2013.11.008","article-title":"Lgr5+ stem cells are indispensable for radiation-induced intestinal regeneration","volume":"14","author":"Metcalfe","year":"2014","journal-title":"Cell Stem Cell"},{"key":"10.1016\/j.trecan.2026.02.006_bb0145","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1016\/j.stem.2016.01.001","article-title":"Replacement of lost Lgr5-positive stem cells through plasticity of their enterocyte-lineage daughters","volume":"18","author":"Tetteh","year":"2016","journal-title":"Cell Stem Cell"},{"key":"10.1016\/j.trecan.2026.02.006_bb0150","doi-asserted-by":"crossref","first-page":"1099","DOI":"10.1038\/ncb2581","article-title":"Dll1+ secretory progenitor cells revert to stem cells upon crypt damage","volume":"14","author":"van Es","year":"2012","journal-title":"Nat. Cell Biol."},{"key":"10.1016\/j.trecan.2026.02.006_bb0155","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1038\/embor.2011.52","article-title":"Lgr4 is required for Paneth cell differentiation and maintenance of intestinal stem cells ex vivo","volume":"12","author":"Mustata","year":"2011","journal-title":"EMBO Rep."},{"key":"10.1016\/j.trecan.2026.02.006_bb0160","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1038\/nature22313","article-title":"Non-equivalence of Wnt and R-spondin ligands during Lgr5+ intestinal stem cell self-renewal","volume":"545","author":"Yan","year":"2017","journal-title":"Nature"},{"key":"10.1016\/j.trecan.2026.02.006_bb0165","doi-asserted-by":"crossref","first-page":"2054","DOI":"10.1128\/MCB.00272-12","article-title":"LGR5 interacts and cointernalizes with Wnt receptors to modulate Wnt\/\u03b2-catenin signaling","volume":"32","author":"Carmon","year":"2012","journal-title":"Mol. Cell. Biol."},{"key":"10.1016\/j.trecan.2026.02.006_bb0170","doi-asserted-by":"crossref","first-page":"10286","DOI":"10.1074\/jbc.M112.447540","article-title":"Constitutive internalization of the leucine-rich G protein-coupled receptor-5 (LGR5) to the trans-Golgi network","volume":"288","author":"Snyder","year":"2013","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.trecan.2026.02.006_bb0175","doi-asserted-by":"crossref","first-page":"7208","DOI":"10.1074\/jbc.M116.756635","article-title":"Inhibiting clathrin-mediated endocytosis of the leucine-rich G protein-coupled receptor-5 diminishes cell fitness","volume":"292","author":"Snyder","year":"2017","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.trecan.2026.02.006_bb0180","article-title":"Cetuximab increases LGR5 expression and augments LGR5-targeting antibody-drug conjugate efficacy in patient-derived colorectal cancer models","volume":"6","author":"High","year":"2025","journal-title":"Cell Rep. Med."},{"key":"10.1016\/j.trecan.2026.02.006_bb0185","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1038\/nature11308","article-title":"Tumour suppressor RNF43 is a stem-cell E3 ligase that induces endocytosis of Wnt receptors","volume":"488","author":"Koo","year":"2012","journal-title":"Nature"},{"key":"10.1016\/j.trecan.2026.02.006_bb0190","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1038\/nature11019","article-title":"ZNRF3 promotes Wnt receptor turnover in an R-spondin-sensitive manner","volume":"485","author":"Hao","year":"2012","journal-title":"Nature"},{"key":"10.1016\/j.trecan.2026.02.006_bb0195","doi-asserted-by":"crossref","first-page":"628","DOI":"10.1053\/j.gastro.2006.08.039","article-title":"The intestinal Wnt\/TCF signature","volume":"132","author":"Van der Flier","year":"2007","journal-title":"Gastroenterology"},{"key":"10.1016\/j.trecan.2026.02.006_bb0200","doi-asserted-by":"crossref","first-page":"1345","DOI":"10.1101\/gad.219915.113","article-title":"The structural basis of R-spondin recognition by LGR5 and RNF43","volume":"27","author":"Chen","year":"2013","journal-title":"Genes Dev."},{"key":"10.1016\/j.trecan.2026.02.006_bb0205","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/j.jsb.2015.05.008","article-title":"Crystal structure of R-spondin 2 in complex with the ectodomains of its receptors LGR5 and ZNRF3","volume":"191","author":"Zebisch","year":"2015","journal-title":"J. Struct. Biol."},{"key":"10.1016\/j.trecan.2026.02.006_bb0210","doi-asserted-by":"crossref","DOI":"10.1126\/scisignal.aaz4051","article-title":"Unlike LGR4, LGR5 potentiates Wnt-\u03b2-catenin signaling without sequestering E3 ligases","volume":"13","author":"Park","year":"2020","journal-title":"Sci. Signal."},{"key":"10.1016\/j.trecan.2026.02.006_bb0215","doi-asserted-by":"crossref","first-page":"10796","DOI":"10.1038\/s41598-023-37856-w","article-title":"LGR4 and LGR5 form distinct homodimers that only LGR4 complexes with RNF43\/ZNRF3 to provide high affinity binding of R-spondin ligands","volume":"13","author":"Toh","year":"2023","journal-title":"Sci. Rep."},{"key":"10.1016\/j.trecan.2026.02.006_bb0220","doi-asserted-by":"crossref","first-page":"E1221","DOI":"10.1073\/pnas.1323106111","article-title":"RSPO-LGR4 functions via IQGAP1 to potentiate Wnt signaling","volume":"111","author":"Carmon","year":"2014","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.trecan.2026.02.006_bb0225","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0022733","article-title":"LGR5 is a negative regulator of tumourigenicity, antagonizes Wnt signalling and regulates cell adhesion in colorectal cancer cell lines","volume":"6","author":"Walker","year":"2011","journal-title":"PLoS One"},{"key":"10.1016\/j.trecan.2026.02.006_bb0230","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/j.gde.2005.12.007","article-title":"Balancing cell adhesion and Wnt signaling, the key role of beta-catenin","volume":"16","author":"Brembeck","year":"2006","journal-title":"Curr. Opin. Genet. Dev."},{"key":"10.1016\/j.trecan.2026.02.006_bb0235","doi-asserted-by":"crossref","first-page":"1580","DOI":"10.1158\/1535-7163.MCT-16-0114","article-title":"LGR5-targeted antibody-drug conjugate eradicates gastrointestinal tumors and prevents recurrence","volume":"15","author":"Gong","year":"2016","journal-title":"Mol. Cancer Ther."},{"key":"10.1016\/j.trecan.2026.02.006_bb0240","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1007\/s10555-024-10239-x","article-title":"LGR5: an emerging therapeutic target for cancer metastasis and chemotherapy resistance","volume":"44","author":"Wang","year":"2025","journal-title":"Cancer Metastasis Rev."},{"key":"10.1016\/j.trecan.2026.02.006_bb0245","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.aac7433","article-title":"Targeting LGR5+ cells with an antibody-drug conjugate for the treatment of colon cancer","volume":"7","author":"Junttila","year":"2015","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.trecan.2026.02.006_bb0250","doi-asserted-by":"crossref","first-page":"4690","DOI":"10.3390\/ijms22094690","article-title":"The role of LGR4 (GPR48) in normal and cancer processes","volume":"22","author":"Ordaz-Ramos","year":"2021","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.trecan.2026.02.006_bb0255","doi-asserted-by":"crossref","first-page":"11623","DOI":"10.1158\/0008-5472.CAN-06-2629","article-title":"Up-regulation of GPR48 induced by down-regulation of p27Kip1 enhances carcinoma cell invasiveness and metastasis","volume":"66","author":"Gao","year":"2006","journal-title":"Cancer Res."},{"key":"10.1016\/j.trecan.2026.02.006_bb0260","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0037137","article-title":"LGR6 is a high affinity receptor of R-spondins and potentially functions as a tumor suppressor","volume":"7","author":"Gong","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.trecan.2026.02.006_bb0265","doi-asserted-by":"crossref","first-page":"608","DOI":"10.1038\/nature07602","article-title":"Crypt stem cells as the cells-of-origin of intestinal cancer","volume":"457","author":"Barker","year":"2009","journal-title":"Nature"},{"key":"10.1016\/j.trecan.2026.02.006_bb0270","doi-asserted-by":"crossref","first-page":"730","DOI":"10.1126\/science.1224676","article-title":"Lineage tracing reveals Lgr5+ stem cell activity in mouse intestinal adenomas","volume":"337","author":"Schepers","year":"2012","journal-title":"Science"},{"key":"10.1016\/j.trecan.2026.02.006_bb0275","doi-asserted-by":"crossref","first-page":"947","DOI":"10.1038\/s41586-024-08150-0","article-title":"Progressive plasticity during colorectal cancer metastasis","volume":"637","author":"Moorman","year":"2025","journal-title":"Nature"},{"key":"10.1016\/j.trecan.2026.02.006_bb0280","doi-asserted-by":"crossref","first-page":"676","DOI":"10.1038\/nature21713","article-title":"A distinct role for Lgr5+ stem cells in primary and metastatic colon cancer","volume":"543","author":"de Sousa e Melo, F.","year":"2017","journal-title":"Nature"},{"key":"10.1016\/j.trecan.2026.02.006_bb0285","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1038\/nature22081","article-title":"Visualization and targeting of LGR5+ human colon cancer stem cells","volume":"545","author":"Shimokawa","year":"2017","journal-title":"Nature"},{"key":"10.1016\/j.trecan.2026.02.006_bb0290","doi-asserted-by":"crossref","first-page":"2631","DOI":"10.1002\/stem.1257","article-title":"LGR5-positive colon cancer stem cells interconvert with drug-resistant LGR5-negative cells and are capable of tumor reconstitution","volume":"30","author":"Kobayashi","year":"2012","journal-title":"Stem Cells"},{"key":"10.1016\/j.trecan.2026.02.006_bb0295","doi-asserted-by":"crossref","first-page":"2233","DOI":"10.1038\/s44321-024-00121-2","article-title":"Novel immunotherapeutics against LGR5 to target multiple cancer types","volume":"16","author":"Chen","year":"2024","journal-title":"EMBO Mol. Med."},{"key":"10.1016\/j.trecan.2026.02.006_bb0300","doi-asserted-by":"crossref","first-page":"943","DOI":"10.3390\/pharmaceutics16070943","article-title":"Antitumor activity of a pyrrolobenzodiazepine antibody\u2013drug conjugate targeting LGR5 in preclinical models of neuroblastoma","volume":"16","author":"Tu","year":"2024","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.trecan.2026.02.006_bb0305","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1016\/j.stem.2020.02.008","article-title":"Plasticity of Lgr5-negative cancer cells drives metastasis in colorectal cancer","volume":"26","author":"Fumagalli","year":"2020","journal-title":"Cell Stem Cell"},{"key":"10.1016\/j.trecan.2026.02.006_bb0310","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1038\/s41586-022-05402-9","article-title":"Metastatic recurrence in colorectal cancer arises from residual EMP1+ cells","volume":"611","author":"Ca\u00f1ellas-Socias","year":"2022","journal-title":"Nature"},{"key":"10.1016\/j.trecan.2026.02.006_bb0315","first-page":"28","article-title":"L1CAM defines the regenerative origin of metastasis-initiating cells in colorectal cancer","volume":"1","author":"Ganesh","year":"2020","journal-title":"Nat. Can."},{"key":"10.1016\/j.trecan.2026.02.006_bb0320","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1158\/1535-7163.MCT-22-0415","article-title":"Loss of LGR5 through therapy-induced downregulation or gene ablation is associated with resistance and enhanced MET-STAT3 signaling in colorectal cancer cells","volume":"22","author":"Posey","year":"2023","journal-title":"Mol. Cancer Ther."},{"key":"10.1016\/j.trecan.2026.02.006_bb0325","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1038\/s41588-024-02058-1","article-title":"Oncofetal reprogramming drives phenotypic plasticity in WNT-dependent colorectal cancer","volume":"57","author":"Mzoughi","year":"2025","journal-title":"Nat. Genet."},{"key":"10.1016\/j.trecan.2026.02.006_bb0330","first-page":"1052","article-title":"Mex3a marks drug-tolerant persister colorectal cancer cells that mediate relapse after chemotherapy","volume":"3","author":"\u00c1lvarez-Varela","year":"2022","journal-title":"Nat. Can."},{"key":"10.1016\/j.trecan.2026.02.006_bb0335","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1158\/2159-8290.CD-25-0679","article-title":"A plastic EMP1+ to LGR5+ cell state conversion as a bypass to KRAS-G12D pharmacological inhibition in metastatic colorectal cancer","volume":"16","author":"Centonze","year":"2025","journal-title":"Cancer Discov."},{"key":"10.1016\/j.trecan.2026.02.006_bb0340","first-page":"418","article-title":"Functional patient-derived organoid screenings identify MCLA-158 as a therapeutic EGFR \u00d7 LGR5 bispecific antibody with efficacy in epithelial tumors","volume":"3","author":"Herpers","year":"2022","journal-title":"Nat. Can."},{"key":"10.1016\/j.trecan.2026.02.006_bb0345","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.aax8313","article-title":"Colorectal cancer residual disease at maximal response to EGFR blockade displays a druggable Paneth cell-like phenotype","volume":"12","author":"Lupo","year":"2020","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.trecan.2026.02.006_bb0350","doi-asserted-by":"crossref","first-page":"748","DOI":"10.1038\/s41586-025-09916-w","article-title":"MAPK-driven epithelial cell plasticity drives colorectal cancer therapeutic resistance","volume":"650","author":"White","year":"2025","journal-title":"Nature"},{"key":"10.1016\/j.trecan.2026.02.006_bb0355","doi-asserted-by":"crossref","first-page":"2197","DOI":"10.1038\/s41467-019-09898-0","article-title":"MEK inhibitors activate Wnt signalling and induce stem cell plasticity in colorectal cancer","volume":"10","author":"Zhan","year":"2019","journal-title":"Nat. Commun."},{"key":"10.1016\/j.trecan.2026.02.006_bb0360","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1038\/bjc.2017.412","article-title":"LGR5 expression is regulated by EGF in early colorectal adenomas and governs EGFR inhibitor sensitivity","volume":"118","author":"Morgan","year":"2018","journal-title":"Br. J. Cancer"},{"key":"10.1016\/j.trecan.2026.02.006_bb0365","doi-asserted-by":"crossref","first-page":"1410","DOI":"10.1038\/s41416-018-0118-6","article-title":"Targeting LGR5 in colorectal cancer: therapeutic gold or too plastic?","volume":"118","author":"Morgan","year":"2018","journal-title":"Br. J. Cancer"},{"key":"10.1016\/j.trecan.2026.02.006_bb0370","doi-asserted-by":"crossref","first-page":"2448","DOI":"10.1021\/acs.molpharmaceut.8b00275","article-title":"Evaluation of anti-LGR5 antibodies by ImmunoPET for imaging colorectal tumors and development of antibody\u2013drug conjugates","volume":"15","author":"Azhdarinia","year":"2018","journal-title":"Mol. Pharm."},{"key":"10.1016\/j.trecan.2026.02.006_bb0375","doi-asserted-by":"crossref","first-page":"S29","DOI":"10.1016\/S0959-8049(16)32668-5","article-title":"Initial results from a phase 1a\/b study of OMP-131R10, a first-in-class anti-RSPO3 antibody, in advanced solid tumors and previously treated metastatic colorectal cancer (CRC)","volume":"69","author":"Bendell","year":"2016","journal-title":"Eur. J. Cancer"},{"key":"10.1016\/j.trecan.2026.02.006_bb0380","doi-asserted-by":"crossref","first-page":"938","DOI":"10.1136\/gutjnl-2020-322835","article-title":"Chromatin state dynamics confers specific therapeutic strategies in enhancer subtypes of colorectal cancer","volume":"71","author":"Orouji","year":"2022","journal-title":"Gut"},{"key":"10.1016\/j.trecan.2026.02.006_bb0385","doi-asserted-by":"crossref","first-page":"12572","DOI":"10.1021\/acs.jmedchem.1c00395","article-title":"Drug conjugates of antagonistic RSPO4 mutant for simultaneous targeting of LGR4\/5\/6 for cancer treatment","volume":"64","author":"Cui","year":"2021","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.trecan.2026.02.006_bb0390","doi-asserted-by":"crossref","first-page":"1218","DOI":"10.1038\/s41416-025-03121-2","article-title":"Anti-tumor activity of camptothecin analog conjugate of an RSPO4-based peptibody targeting LGR4\/5\/6 in preclinical models of colorectal cancer","volume":"133","author":"Toh","year":"2025","journal-title":"Br. J. Cancer"},{"key":"10.1016\/j.trecan.2026.02.006_bb0395","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1021\/acs.bioconjchem.1c00008","article-title":"Therapeutic targeting of tumor cells rich in LGR stem cell receptors","volume":"32","author":"Yu","year":"2021","journal-title":"Bioconjug. Chem."},{"key":"10.1016\/j.trecan.2026.02.006_bb0400","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1124\/jpet.122.001495","article-title":"Exploiting the receptor-binding domains of R-spondin 1 to target leucine-rich repeat-containing G-coupled protein receptor 5-expressing stem cells in ovarian cancer","volume":"385","author":"Wong","year":"2023","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.trecan.2026.02.006_bb0405","doi-asserted-by":"crossref","first-page":"1665","DOI":"10.3390\/cancers17101665","article-title":"Petosemtamab, a bispecific antibody targeting epidermal growth factor receptor (EGFR) and leucine-rich G repeat-containing protein-coupled receptor (LGR5) designed for broad clinical applications","volume":"17","author":"Lundberg","year":"2025","journal-title":"Cancers"},{"key":"10.1016\/j.trecan.2026.02.006_bb0410","doi-asserted-by":"crossref","first-page":"B033","DOI":"10.1158\/1535-7163.TARG-25-B033","article-title":"Abstract B033: petosemtamab (MCLA-158) monotherapy or with chemotherapy in metastatic colorectal cancer: preliminary antitumor activity and safety data from a phase 2 trial","volume":"24","author":"Khushman","year":"2025","journal-title":"Mol. Cancer Ther."},{"key":"10.1016\/j.trecan.2026.02.006_bb0415","first-page":"B033","article-title":"T cell engagers: expanding horizons in oncology and beyond","volume":"24","author":"Albayrak","year":"2025","journal-title":"Br. J. Cancer"},{"key":"10.1016\/j.trecan.2026.02.006_bb0420","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1038\/s41392-025-02269-w","article-title":"CAR-T cell therapy for cancer: current challenges and future directions","volume":"10","author":"Zugasti","year":"2025","journal-title":"Signal Transduct. Target. Ther."},{"key":"10.1016\/j.trecan.2026.02.006_bb0425","doi-asserted-by":"crossref","DOI":"10.1016\/j.canlet.2023.216191","article-title":"G protein-coupled receptor-targeting antibody-drug conjugates: current status and future directions","volume":"564","author":"High","year":"2023","journal-title":"Cancer Lett."},{"key":"10.1016\/j.trecan.2026.02.006_bb0430","doi-asserted-by":"crossref","first-page":"2196","DOI":"10.1158\/1541-7786.MCR-19-0436","article-title":"GPR56 drives colorectal tumor growth and promotes drug resistance through upregulation of MDR1 expression via a RhoA-mediated mechanism","volume":"17","author":"Zhang","year":"2019","journal-title":"Mol. Cancer Res."},{"key":"10.1016\/j.trecan.2026.02.006_bb0435","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1182\/blood-2018-99-116956","article-title":"Lgr5 enables positive B-cell selection and tumor-initiation in B-cell malignancies","volume":"132","author":"Cosgun","year":"2018","journal-title":"Blood"}],"container-title":["Trends in Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2405803326000373?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2405803326000373?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,6,15]],"date-time":"2026-06-15T13:39:10Z","timestamp":1781530750000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2405803326000373"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6]]},"references-count":87,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2026,6]]}},"alternative-id":["S2405803326000373"],"URL":"https:\/\/doi.org\/10.1016\/j.trecan.2026.02.006","relation":{},"ISSN":["2405-8033"],"issn-type":[{"value":"2405-8033","type":"print"}],"subject":[],"published":{"date-parts":[[2026,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"LGR5: from stem cell marker to therapeutic target","name":"articletitle","label":"Article Title"},{"value":"Trends in Cancer","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.trecan.2026.02.006","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Author(s). Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}